United States Primary Antibodies Market Report 2017

October 2017 | 113 pages | ID: UC3D2DD840CPEN
QYResearch

Abstracts

In this report, the United States Primary Antibodies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Primary Antibodies in these regions, from 2012 to 2022 (forecast).

United States Primary Antibodies market competition by top manufacturers/players, with Primary Antibodies sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abcam
• BD
• Santa Cruz Biotechnology
• Sigma Aldrich Corporation
• Thermo Fisher Scientific
• Bio-Rad
• R&D Systems
• MBL
• CST
• Merk
• Novus Biologicals
• PeproTech
• Cayman
• AbMax Biotechnology
• MABTech
• KPL
• Abnova

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Human
• Animal

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Primary Antibodies for each application, including

• ELISA
• Western Blot
• Immunostaining
• Immunohistochemistry
• Immunocytochemistry
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Primary Antibodies Market Report 2017

1 PRIMARY ANTIBODIES OVERVIEW

1.1 Product Overview and Scope of Primary Antibodies
1.2 Classification of Primary Antibodies by Product Category
  1.2.1 United States Primary Antibodies Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Primary Antibodies Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Human
  1.2.4 Animal
1.3 United States Primary Antibodies Market by Application/End Users
  1.3.1 United States Primary Antibodies Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 ELISA
  1.3.3 Western Blot
  1.3.4 Immunostaining
  1.3.5 Immunohistochemistry
  1.3.6 Immunocytochemistry
  1.3.7 Other
1.4 United States Primary Antibodies Market by Region
  1.4.1 United States Primary Antibodies Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Primary Antibodies Status and Prospect (2012-2022)
  1.4.3 Southwest Primary Antibodies Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Primary Antibodies Status and Prospect (2012-2022)
  1.4.5 New England Primary Antibodies Status and Prospect (2012-2022)
  1.4.6 The South Primary Antibodies Status and Prospect (2012-2022)
  1.4.7 The Midwest Primary Antibodies Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Primary Antibodies (2012-2022)
  1.5.1 United States Primary Antibodies Sales and Growth Rate (2012-2022)
  1.5.2 United States Primary Antibodies Revenue and Growth Rate (2012-2022)

2 UNITED STATES PRIMARY ANTIBODIES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Primary Antibodies Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Primary Antibodies Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Primary Antibodies Average Price by Players/Suppliers (2012-2017)
2.4 United States Primary Antibodies Market Competitive Situation and Trends
  2.4.1 United States Primary Antibodies Market Concentration Rate
  2.4.2 United States Primary Antibodies Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Primary Antibodies Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PRIMARY ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Primary Antibodies Sales and Market Share by Region (2012-2017)
3.2 United States Primary Antibodies Revenue and Market Share by Region (2012-2017)
3.3 United States Primary Antibodies Price by Region (2012-2017)

4 UNITED STATES PRIMARY ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Primary Antibodies Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Primary Antibodies Revenue and Market Share by Type (2012-2017)
4.3 United States Primary Antibodies Price by Type (2012-2017)
4.4 United States Primary Antibodies Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PRIMARY ANTIBODIES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Primary Antibodies Sales and Market Share by Application (2012-2017)
5.2 United States Primary Antibodies Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PRIMARY ANTIBODIES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abcam
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Primary Antibodies Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abcam Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 BD
  6.2.2 Primary Antibodies Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 BD Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Santa Cruz Biotechnology
  6.3.2 Primary Antibodies Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Santa Cruz Biotechnology Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sigma Aldrich Corporation
  6.4.2 Primary Antibodies Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sigma Aldrich Corporation Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Thermo Fisher Scientific
  6.5.2 Primary Antibodies Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Thermo Fisher Scientific Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bio-Rad
  6.6.2 Primary Antibodies Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bio-Rad Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 R&D Systems
  6.7.2 Primary Antibodies Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 R&D Systems Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MBL
  6.8.2 Primary Antibodies Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MBL Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 CST
  6.9.2 Primary Antibodies Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CST Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merk
  6.10.2 Primary Antibodies Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merk Primary Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Novus Biologicals
6.12 PeproTech
6.13 Cayman
6.14 AbMax Biotechnology
6.15 MABTech
6.16 KPL
6.17 Abnova

7 PRIMARY ANTIBODIES MANUFACTURING COST ANALYSIS

7.1 Primary Antibodies Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Primary Antibodies

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Primary Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Primary Antibodies Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PRIMARY ANTIBODIES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Primary Antibodies Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Primary Antibodies Sales Volume Forecast by Type (2017-2022)
11.3 United States Primary Antibodies Sales Volume Forecast by Application (2017-2022)
11.4 United States Primary Antibodies Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Primary Antibodies
Figure United States Primary Antibodies Market Size (K Pcs) by Type (2012-2022)
Figure United States Primary Antibodies Sales Volume Market Share by Type (Product Category) in 2016
Figure Human Product Picture
Figure Animal Product Picture
Figure United States Primary Antibodies Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Primary Antibodies by Application in 2016
Figure ELISA Examples
Table Key Downstream Customer in ELISA
Figure Western Blot Examples
Table Key Downstream Customer in Western Blot
Figure Immunostaining Examples
Table Key Downstream Customer in Immunostaining
Figure Immunohistochemistry Examples
Table Key Downstream Customer in Immunohistochemistry
Figure Immunocytochemistry Examples
Table Key Downstream Customer in Immunocytochemistry
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Primary Antibodies Market Size (Million USD) by Region (2012-2022)
Figure The West Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Primary Antibodies Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Primary Antibodies Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Primary Antibodies Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Primary Antibodies Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Primary Antibodies Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Primary Antibodies Sales Share by Players/Suppliers
Figure 2017 United States Primary Antibodies Sales Share by Players/Suppliers
Figure United States Primary Antibodies Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Primary Antibodies Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Primary Antibodies Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Primary Antibodies Revenue Share by Players/Suppliers
Figure 2017 United States Primary Antibodies Revenue Share by Players/Suppliers
Table United States Market Primary Antibodies Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Primary Antibodies Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Primary Antibodies Market Share of Top 3 Players/Suppliers
Figure United States Primary Antibodies Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Primary Antibodies Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Primary Antibodies Product Category
Table United States Primary Antibodies Sales (K Pcs) by Region (2012-2017)
Table United States Primary Antibodies Sales Share by Region (2012-2017)
Figure United States Primary Antibodies Sales Share by Region (2012-2017)
Figure United States Primary Antibodies Sales Market Share by Region in 2016
Table United States Primary Antibodies Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Primary Antibodies Revenue Share by Region (2012-2017)
Figure United States Primary Antibodies Revenue Market Share by Region (2012-2017)
Figure United States Primary Antibodies Revenue Market Share by Region in 2016
Table United States Primary Antibodies Price (USD/Pcs) by Region (2012-2017)
Table United States Primary Antibodies Sales (K Pcs) by Type (2012-2017)
Table United States Primary Antibodies Sales Share by Type (2012-2017)
Figure United States Primary Antibodies Sales Share by Type (2012-2017)
Figure United States Primary Antibodies Sales Market Share by Type in 2016
Table United States Primary Antibodies Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Primary Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Primary Antibodies by Type (2012-2017)
Figure Revenue Market Share of Primary Antibodies by Type in 2016
Table United States Primary Antibodies Price (USD/Pcs) by Types (2012-2017)
Figure United States Primary Antibodies Sales Growth Rate by Type (2012-2017)
Table United States Primary Antibodies Sales (K Pcs) by Application (2012-2017)
Table United States Primary Antibodies Sales Market Share by Application (2012-2017)
Figure United States Primary Antibodies Sales Market Share by Application (2012-2017)
Figure United States Primary Antibodies Sales Market Share by Application in 2016
Table United States Primary Antibodies Sales Growth Rate by Application (2012-2017)
Figure United States Primary Antibodies Sales Growth Rate by Application (2012-2017)
Table Abcam Basic Information List
Table Abcam Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abcam Primary Antibodies Sales Growth Rate (2012-2017)
Figure Abcam Primary Antibodies Sales Market Share in United States (2012-2017)
Figure Abcam Primary Antibodies Revenue Market Share in United States (2012-2017)
Table BD Basic Information List
Table BD Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BD Primary Antibodies Sales Growth Rate (2012-2017)
Figure BD Primary Antibodies Sales Market Share in United States (2012-2017)
Figure BD Primary Antibodies Revenue Market Share in United States (2012-2017)
Table Santa Cruz Biotechnology Basic Information List
Table Santa Cruz Biotechnology Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Santa Cruz Biotechnology Primary Antibodies Sales Growth Rate (2012-2017)
Figure Santa Cruz Biotechnology Primary Antibodies Sales Market Share in United States (2012-2017)
Figure Santa Cruz Biotechnology Primary Antibodies Revenue Market Share in United States (2012-2017)
Table Sigma Aldrich Corporation Basic Information List
Table Sigma Aldrich Corporation Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sigma Aldrich Corporation Primary Antibodies Sales Growth Rate (2012-2017)
Figure Sigma Aldrich Corporation Primary Antibodies Sales Market Share in United States (2012-2017)
Figure Sigma Aldrich Corporation Primary Antibodies Revenue Market Share in United States (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Thermo Fisher Scientific Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Primary Antibodies Sales Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Primary Antibodies Sales Market Share in United States (2012-2017)
Figure Thermo Fisher Scientific Primary Antibodies Revenue Market Share in United States (2012-2017)
Table Bio-Rad Basic Information List
Table Bio-Rad Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bio-Rad Primary Antibodies Sales Growth Rate (2012-2017)
Figure Bio-Rad Primary Antibodies Sales Market Share in United States (2012-2017)
Figure Bio-Rad Primary Antibodies Revenue Market Share in United States (2012-2017)
Table R&D Systems Basic Information List
Table R&D Systems Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure R&D Systems Primary Antibodies Sales Growth Rate (2012-2017)
Figure R&D Systems Primary Antibodies Sales Market Share in United States (2012-2017)
Figure R&D Systems Primary Antibodies Revenue Market Share in United States (2012-2017)
Table MBL Basic Information List
Table MBL Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MBL Primary Antibodies Sales Growth Rate (2012-2017)
Figure MBL Primary Antibodies Sales Market Share in United States (2012-2017)
Figure MBL Primary Antibodies Revenue Market Share in United States (2012-2017)
Table CST Basic Information List
Table CST Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CST Primary Antibodies Sales Growth Rate (2012-2017)
Figure CST Primary Antibodies Sales Market Share in United States (2012-2017)
Figure CST Primary Antibodies Revenue Market Share in United States (2012-2017)
Table Merk Basic Information List
Table Merk Primary Antibodies Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merk Primary Antibodies Sales Growth Rate (2012-2017)
Figure Merk Primary Antibodies Sales Market Share in United States (2012-2017)
Figure Merk Primary Antibodies Revenue Market Share in United States (2012-2017)
Table Novus Biologicals Basic Information List
Table PeproTech Basic Information List
Table Cayman Basic Information List
Table AbMax Biotechnology Basic Information List
Table MABTech Basic Information List
Table KPL Basic Information List
Table Abnova Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Primary Antibodies
Figure Manufacturing Process Analysis of Primary Antibodies
Figure Primary Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Primary Antibodies Major Players/Suppliers in 2016
Table Major Buyers of Primary Antibodies
Table Distributors/Traders List
Figure United States Primary Antibodies Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Primary Antibodies Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Primary Antibodies Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Primary Antibodies Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Primary Antibodies Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Primary Antibodies Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Primary Antibodies Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Primary Antibodies Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Primary Antibodies Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Primary Antibodies Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Primary Antibodies Sales Volume Share Forecast by Region (2017-2022)
Figure United States Primary Antibodies Sales Volume Share Forecast by Region (2017-2022)
Figure United States Primary Antibodies Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources